ニラパリブトシレートのグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Niraparib Tosylate Market Insights and Forecast to 2027

• レポートコード：QY2112C00630
• 出版社/出版日：QYResearch / 2021年12月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、87ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査資料はニラパリブトシレートの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ニラパリブトシレートの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99.0％以上、その他）、用途別市場規模（腫瘍、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・ニラパリブトシレートの世界市場概要
・メーカー別の競争状況、市場シェア
・ニラパリブトシレートの種類別市場規模：純度99.0％以上、その他
・ニラパリブトシレートの用途別市場規模：腫瘍、その他
・北米のニラパリブトシレート市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ）
・ヨーロッパのニラパリブトシレート市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス）
・アジアのニラパリブトシレート市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国）
・中南米のニラパリブトシレート市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル）
・中東・アフリカのニラパリブトシレート市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア）
・企業情報：Teva api、Zhejiang Tuopu Pharmaceutical、ScinoPharm Taiwan
・ニラパリブトシレートのバリューチェーン・販売チャネル分析
・ニラパリブトシレートの世界市場動向

Market Analysis and Insights: Global Niraparib Tosylate Market
The global Niraparib Tosylate market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Niraparib Tosylate Scope and Segment
Niraparib Tosylate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Niraparib Tosylate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 99.0％
Other

Segment by Application
Oncology
Other

By Company
Teva api
Zhejiang Tuopu Pharmaceutical
ScinoPharm Taiwan

Production by Region
North America
Europe
China
India

Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Niraparib Tosylate Product Introduction
1.2 Market by Type
1.2.1 Global Niraparib Tosylate Market Size Growth Rate by Type
1.2.2 Purity ≥ 99.0％
1.2.3 Other
1.3 Market by Application
1.3.1 Global Niraparib Tosylate Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Niraparib Tosylate Production
2.1 Global Niraparib Tosylate Production Capacity (2016-2027)
2.2 Global Niraparib Tosylate Production by Region: 2016 VS 2021 VS 2027
2.3 Global Niraparib Tosylate Production by Region
2.3.1 Global Niraparib Tosylate Historic Production by Region (2016-2021)
2.3.2 Global Niraparib Tosylate Forecasted Production by Region (2022-2027)
2.4 North America
2.5 Europe
2.6 China
2.7 India

3 Global Niraparib Tosylate Sales in Volume & Value Estimates and Forecasts
3.1 Global Niraparib Tosylate Sales Estimates and Forecasts 2016-2027
3.2 Global Niraparib Tosylate Revenue Estimates and Forecasts 2016-2027
3.3 Global Niraparib Tosylate Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Niraparib Tosylate Regions by Sales
3.4.1 Global Top Niraparib Tosylate Regions by Sales (2016-2021)
3.4.2 Global Top Niraparib Tosylate Regions by Sales (2022-2027)
3.5 Global Top Niraparib Tosylate Regions by Revenue
3.5.1 Global Top Niraparib Tosylate Regions by Revenue (2016-2021)
3.5.2 Global Top Niraparib Tosylate Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa

4 Competition by Manufactures
4.1 Global Niraparib Tosylate Production Capacity by Manufacturers
4.2 Global Niraparib Tosylate Sales by Manufacturers
4.2.1 Global Top Niraparib Tosylate Manufacturers by Sales (2016-2021)
4.2.2 Global Top Niraparib Tosylate Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Niraparib Tosylate Sales in 2020
4.3 Global Niraparib Tosylate Revenue by Manufacturers
4.3.1 Global Top Niraparib Tosylate Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Niraparib Tosylate Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Niraparib Tosylate Revenue in 2020
4.4 Global Niraparib Tosylate Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Niraparib Tosylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Niraparib Tosylate Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type
5.1 Global Niraparib Tosylate Sales by Type
5.1.1 Global Niraparib Tosylate Historical Sales by Type (2016-2021)
5.1.2 Global Niraparib Tosylate Forecasted Sales by Type (2022-2027)
5.1.3 Global Niraparib Tosylate Sales Market Share by Type (2016-2027)
5.2 Global Niraparib Tosylate Revenue by Type
5.2.1 Global Niraparib Tosylate Historical Revenue by Type (2016-2021)
5.2.2 Global Niraparib Tosylate Forecasted Revenue by Type (2022-2027)
5.2.3 Global Niraparib Tosylate Revenue Market Share by Type (2016-2027)
5.3 Global Niraparib Tosylate Price by Type
5.3.1 Global Niraparib Tosylate Price by Type (2016-2021)
5.3.2 Global Niraparib Tosylate Price Forecast by Type (2022-2027)

6 Market Size by Application
6.1 Global Niraparib Tosylate Sales by Application
6.1.1 Global Niraparib Tosylate Historical Sales by Application (2016-2021)
6.1.2 Global Niraparib Tosylate Forecasted Sales by Application (2022-2027)
6.1.3 Global Niraparib Tosylate Sales Market Share by Application (2016-2027)
6.2 Global Niraparib Tosylate Revenue by Application
6.2.1 Global Niraparib Tosylate Historical Revenue by Application (2016-2021)
6.2.2 Global Niraparib Tosylate Forecasted Revenue by Application (2022-2027)
6.2.3 Global Niraparib Tosylate Revenue Market Share by Application (2016-2027)
6.3 Global Niraparib Tosylate Price by Application
6.3.1 Global Niraparib Tosylate Price by Application (2016-2021)
6.3.2 Global Niraparib Tosylate Price Forecast by Application (2022-2027)

7 North America
7.1 North America Niraparib Tosylate Market Size by Type
7.1.1 North America Niraparib Tosylate Sales by Type (2016-2027)
7.1.2 North America Niraparib Tosylate Revenue by Type (2016-2027)
7.2 North America Niraparib Tosylate Market Size by Application
7.2.1 North America Niraparib Tosylate Sales by Application (2016-2027)
7.2.2 North America Niraparib Tosylate Revenue by Application (2016-2027)
7.3 North America Niraparib Tosylate Sales by Country
7.3.1 North America Niraparib Tosylate Sales by Country (2016-2027)
7.3.2 North America Niraparib Tosylate Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada

8 Europe
8.1 Europe Niraparib Tosylate Market Size by Type
8.1.1 Europe Niraparib Tosylate Sales by Type (2016-2027)
8.1.2 Europe Niraparib Tosylate Revenue by Type (2016-2027)
8.2 Europe Niraparib Tosylate Market Size by Application
8.2.1 Europe Niraparib Tosylate Sales by Application (2016-2027)
8.2.2 Europe Niraparib Tosylate Revenue by Application (2016-2027)
8.3 Europe Niraparib Tosylate Sales by Country
8.3.1 Europe Niraparib Tosylate Sales by Country (2016-2027)
8.3.2 Europe Niraparib Tosylate Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia

9 Asia Pacific
9.1 Asia Pacific Niraparib Tosylate Market Size by Type
9.1.1 Asia Pacific Niraparib Tosylate Sales by Type (2016-2027)
9.1.2 Asia Pacific Niraparib Tosylate Revenue by Type (2016-2027)
9.2 Asia Pacific Niraparib Tosylate Market Size by Application
9.2.1 Asia Pacific Niraparib Tosylate Sales by Application (2016-2027)
9.2.2 Asia Pacific Niraparib Tosylate Revenue by Application (2016-2027)
9.3 Asia Pacific Niraparib Tosylate Sales by Region
9.3.1 Asia Pacific Niraparib Tosylate Sales by Region (2016-2027)
9.3.2 Asia Pacific Niraparib Tosylate Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia

10 Latin America
10.1 Latin America Niraparib Tosylate Market Size by Type
10.1.1 Latin America Niraparib Tosylate Sales by Type (2016-2027)
10.1.2 Latin America Niraparib Tosylate Revenue by Type (2016-2027)
10.2 Latin America Niraparib Tosylate Market Size by Application
10.2.1 Latin America Niraparib Tosylate Sales by Application (2016-2027)
10.2.2 Latin America Niraparib Tosylate Revenue by Application (2016-2027)
10.3 Latin America Niraparib Tosylate Sales by Country
10.3.1 Latin America Niraparib Tosylate Sales by Country (2016-2027)
10.3.2 Latin America Niraparib Tosylate Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Niraparib Tosylate Market Size by Type
11.1.1 Middle East and Africa Niraparib Tosylate Sales by Type (2016-2027)
11.1.2 Middle East and Africa Niraparib Tosylate Revenue by Type (2016-2027)
11.2 Middle East and Africa Niraparib Tosylate Market Size by Application
11.2.1 Middle East and Africa Niraparib Tosylate Sales by Application (2016-2027)
11.2.2 Middle East and Africa Niraparib Tosylate Revenue by Application (2016-2027)
11.3 Middle East and Africa Niraparib Tosylate Sales by Country
11.3.1 Middle East and Africa Niraparib Tosylate Sales by Country (2016-2027)
11.3.2 Middle East and Africa Niraparib Tosylate Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE

12 Corporate Profiles
12.1 Teva api
12.1.1 Teva api Corporation Information
12.1.2 Teva api Overview
12.1.3 Teva api Niraparib Tosylate Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Teva api Niraparib Tosylate Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Teva api Recent Developments
12.2 Zhejiang Tuopu Pharmaceutical
12.2.1 Zhejiang Tuopu Pharmaceutical Corporation Information
12.2.2 Zhejiang Tuopu Pharmaceutical Overview
12.2.3 Zhejiang Tuopu Pharmaceutical Niraparib Tosylate Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Zhejiang Tuopu Pharmaceutical Niraparib Tosylate Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Zhejiang Tuopu Pharmaceutical Recent Developments
12.3 ScinoPharm Taiwan
12.3.1 ScinoPharm Taiwan Corporation Information
12.3.2 ScinoPharm Taiwan Overview
12.3.3 ScinoPharm Taiwan Niraparib Tosylate Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 ScinoPharm Taiwan Niraparib Tosylate Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 ScinoPharm Taiwan Recent Developments

13 Industry Chain and Sales Channels Analysis
13.1 Niraparib Tosylate Industry Chain Analysis
13.2 Niraparib Tosylate Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Niraparib Tosylate Production Mode & Process
13.4 Niraparib Tosylate Sales and Marketing
13.4.1 Niraparib Tosylate Sales Channels
13.4.2 Niraparib Tosylate Distributors
13.5 Niraparib Tosylate Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Niraparib Tosylate Industry Trends
14.2 Niraparib Tosylate Market Drivers
14.3 Niraparib Tosylate Market Challenges
14.4 Niraparib Tosylate Market Restraints

15 Key Finding in The Global Niraparib Tosylate Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Niraparib Tosylate Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity ≥ 99.0％
Table 3. Major Manufacturers of Other
Table 4. Global Niraparib Tosylate Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Niraparib Tosylate Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Niraparib Tosylate Production by Region (2016-2021) & (Ton)
Table 7. Global Niraparib Tosylate Production Market Share by Region (2016-2021)
Table 8. Global Niraparib Tosylate Production by Region (2022-2027) & (Ton)
Table 9. Global Niraparib Tosylate Production Market Share by Region (2022-2027)
Table 10. Global Niraparib Tosylate Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Niraparib Tosylate Sales by Region (2016-2021) & (Ton)
Table 12. Global Niraparib Tosylate Sales Market Share by Region (2016-2021)
Table 13. Global Niraparib Tosylate Sales by Region (2022-2027) & (Ton)
Table 14. Global Niraparib Tosylate Sales Market Share by Region (2022-2027)
Table 15. Global Niraparib Tosylate Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Niraparib Tosylate Revenue Market Share by Region (2016-2021)
Table 17. Global Niraparib Tosylate Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Niraparib Tosylate Revenue Market Share by Region (2022-2027)
Table 19. Global Niraparib Tosylate Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Niraparib Tosylate Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Niraparib Tosylate Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Niraparib Tosylate Production Market Share by Manufacturers (2016-2021)
Table 23. Global Niraparib Tosylate Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Niraparib Tosylate Sales Share by Manufacturers (2016-2021)
Table 25. Global Niraparib Tosylate Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Niraparib Tosylate Revenue Share by Manufacturers (2016-2021)
Table 27. Niraparib Tosylate Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Niraparib Tosylate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Niraparib Tosylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Niraparib Tosylate as of 2020)
Table 30. Niraparib Tosylate Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Niraparib Tosylate Product Offered
Table 32. Date of Manufacturers Enter into Niraparib Tosylate Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Niraparib Tosylate Sales by Type (2016-2021) & (Ton)
Table 35. Global Niraparib Tosylate Sales by Type (2022-2027) & (Ton)
Table 36. Global Niraparib Tosylate Sales Share by Type (2016-2021)
Table 37. Global Niraparib Tosylate Sales Share by Type (2022-2027)
Table 38. Global Niraparib Tosylate Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Niraparib Tosylate Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Niraparib Tosylate Revenue Share by Type (2016-2021)
Table 41. Global Niraparib Tosylate Revenue Share by Type (2022-2027)
Table 42. Niraparib Tosylate Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Niraparib Tosylate Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Niraparib Tosylate Sales by Application (2016-2021) & (Ton)
Table 45. Global Niraparib Tosylate Sales by Application (2022-2027) & (Ton)
Table 46. Global Niraparib Tosylate Sales Share by Application (2016-2021)
Table 47. Global Niraparib Tosylate Sales Share by Application (2022-2027)
Table 48. Global Niraparib Tosylate Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Niraparib Tosylate Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Niraparib Tosylate Revenue Share by Application (2016-2021)
Table 51. Global Niraparib Tosylate Revenue Share by Application (2022-2027)
Table 52. Niraparib Tosylate Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Niraparib Tosylate Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Niraparib Tosylate Sales by Type (2016-2021) & (Ton)
Table 55. North America Niraparib Tosylate Sales by Type (2022-2027) & (Ton)
Table 56. North America Niraparib Tosylate Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Niraparib Tosylate Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Niraparib Tosylate Sales by Application (2016-2021) & (Ton)
Table 59. North America Niraparib Tosylate Sales by Application (2022-2027) & (Ton)
Table 60. North America Niraparib Tosylate Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Niraparib Tosylate Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Niraparib Tosylate Sales by Country (2016-2021) & (Ton)
Table 63. North America Niraparib Tosylate Sales by Country (2022-2027) & (Ton)
Table 64. North America Niraparib Tosylate Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Niraparib Tosylate Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Niraparib Tosylate Sales by Type (2016-2021) & (Ton)
Table 67. Europe Niraparib Tosylate Sales by Type (2022-2027) & (Ton)
Table 68. Europe Niraparib Tosylate Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Niraparib Tosylate Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Niraparib Tosylate Sales by Application (2016-2021) & (Ton)
Table 71. Europe Niraparib Tosylate Sales by Application (2022-2027) & (Ton)
Table 72. Europe Niraparib Tosylate Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Niraparib Tosylate Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Niraparib Tosylate Sales by Country (2016-2021) & (Ton)
Table 75. Europe Niraparib Tosylate Sales by Country (2022-2027) & (Ton)
Table 76. Europe Niraparib Tosylate Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Niraparib Tosylate Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Niraparib Tosylate Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Niraparib Tosylate Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Niraparib Tosylate Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Niraparib Tosylate Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Niraparib Tosylate Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Niraparib Tosylate Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Niraparib Tosylate Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Niraparib Tosylate Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Niraparib Tosylate Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Niraparib Tosylate Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Niraparib Tosylate Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Niraparib Tosylate Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Niraparib Tosylate Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Niraparib Tosylate Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Niraparib Tosylate Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Niraparib Tosylate Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Niraparib Tosylate Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Niraparib Tosylate Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Niraparib Tosylate Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Niraparib Tosylate Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Niraparib Tosylate Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Niraparib Tosylate Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Niraparib Tosylate Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Niraparib Tosylate Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Niraparib Tosylate Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Niraparib Tosylate Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Niraparib Tosylate Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Niraparib Tosylate Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Niraparib Tosylate Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Niraparib Tosylate Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Niraparib Tosylate Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Niraparib Tosylate Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Niraparib Tosylate Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Niraparib Tosylate Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Niraparib Tosylate Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Niraparib Tosylate Revenue by Country (2022-2027) & (US$ Million)
Table 114. Teva api Corporation Information
Table 115. Teva api Description and Major Businesses
Table 116. Teva api Niraparib Tosylate Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Teva api Niraparib Tosylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Teva api Recent Development
Table 119. Zhejiang Tuopu Pharmaceutical Corporation Information
Table 120. Zhejiang Tuopu Pharmaceutical Description and Major Businesses
Table 121. Zhejiang Tuopu Pharmaceutical Niraparib Tosylate Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Zhejiang Tuopu Pharmaceutical Niraparib Tosylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Zhejiang Tuopu Pharmaceutical Recent Development
Table 124. ScinoPharm Taiwan Corporation Information
Table 125. ScinoPharm Taiwan Description and Major Businesses
Table 126. ScinoPharm Taiwan Niraparib Tosylate Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. ScinoPharm Taiwan Niraparib Tosylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. ScinoPharm Taiwan Recent Development
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Niraparib Tosylate Distributors List
Table 132. Niraparib Tosylate Customers List
Table 133. Niraparib Tosylate Market Trends
Table 134. Niraparib Tosylate Market Drivers
Table 135. Niraparib Tosylate Market Challenges
Table 136. Niraparib Tosylate Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Niraparib Tosylate Product Picture
Figure 2. Global Niraparib Tosylate Market Share by Type in 2020 & 2027
Figure 3. Purity ≥ 99.0％ Product Picture
Figure 4. Other Product Picture
Figure 5. Global Niraparib Tosylate Market Share by Application in 2020 & 2027
Figure 6. Oncology
Figure 7. Other
Figure 8. Niraparib Tosylate Report Years Considered
Figure 9. Global Niraparib Tosylate Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Niraparib Tosylate Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Niraparib Tosylate Production Market Share by Region (2016-2021)
Figure 12. Global Niraparib Tosylate Production Market Share by Region (2022-2027)
Figure 13. Niraparib Tosylate Production Growth Rate in North America (2016-2027) & (Ton)
Figure 14. Niraparib Tosylate Production Growth Rate in Europe (2016-2027) & (Ton)
Figure 15. Niraparib Tosylate Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Niraparib Tosylate Production Growth Rate in India (2016-2027) & (Ton)
Figure 17. Global Niraparib Tosylate Sales 2016-2027 (Ton)
Figure 18. Global Niraparib Tosylate Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Niraparib Tosylate Revenue 2016-2027 (US$ Million)
Figure 20. Global Niraparib Tosylate Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Niraparib Tosylate Sales Market Share by Region (2016-2021)
Figure 22. Global Niraparib Tosylate Sales Market Share by Region (2022-2027)
Figure 23. North America Niraparib Tosylate Sales YoY (2016-2027) & (Ton)
Figure 24. North America Niraparib Tosylate Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Niraparib Tosylate Sales YoY (2016-2027) & (Ton)
Figure 26. Europe Niraparib Tosylate Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Niraparib Tosylate Sales YoY (2016-2027) & (Ton)
Figure 28. Asia-Pacific Niraparib Tosylate Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Niraparib Tosylate Sales YoY (2016-2027) & (Ton)
Figure 30. Latin America Niraparib Tosylate Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Niraparib Tosylate Sales YoY (2016-2027) & (Ton)
Figure 32. Middle East & Africa Niraparib Tosylate Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Niraparib Tosylate Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Niraparib Tosylate Revenue in 2020
Figure 35. Niraparib Tosylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Niraparib Tosylate Sales Market Share by Type (2016-2027)
Figure 37. Global Niraparib Tosylate Revenue Market Share by Type (2016-2027)
Figure 38. Global Niraparib Tosylate Sales Market Share by Application (2016-2027)
Figure 39. Global Niraparib Tosylate Revenue Market Share by Application (2016-2027)
Figure 40. North America Niraparib Tosylate Sales Market Share by Type (2016-2027)
Figure 41. North America Niraparib Tosylate Revenue Market Share by Type (2016-2027)
Figure 42. North America Niraparib Tosylate Sales Market Share by Application (2016-2027)
Figure 43. North America Niraparib Tosylate Revenue Market Share by Application (2016-2027)
Figure 44. North America Niraparib Tosylate Sales Share by Country (2016-2027)
Figure 45. North America Niraparib Tosylate Revenue Share by Country (2016-2027)
Figure 46. United States Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Niraparib Tosylate Sales Market Share by Type (2016-2027)
Figure 49. Europe Niraparib Tosylate Revenue Market Share by Type (2016-2027)
Figure 50. Europe Niraparib Tosylate Sales Market Share by Application (2016-2027)
Figure 51. Europe Niraparib Tosylate Revenue Market Share by Application (2016-2027)
Figure 52. Europe Niraparib Tosylate Sales Share by Country (2016-2027)
Figure 53. Europe Niraparib Tosylate Revenue Share by Country (2016-2027)
Figure 54. Germany Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 55. France Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Niraparib Tosylate Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Niraparib Tosylate Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Niraparib Tosylate Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Niraparib Tosylate Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Niraparib Tosylate Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Niraparib Tosylate Revenue Share by Region (2016-2027)
Figure 65. China Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 68. India Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Niraparib Tosylate Sales Market Share by Type (2016-2027)
Figure 75. Latin America Niraparib Tosylate Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Niraparib Tosylate Sales Market Share by Application (2016-2027)
Figure 77. Latin America Niraparib Tosylate Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Niraparib Tosylate Sales Share by Country (2016-2027)
Figure 79. Latin America Niraparib Tosylate Revenue Share by Country (2016-2027)
Figure 80. Mexico Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 83. Middle East and Africa Niraparib Tosylate Sales Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Niraparib Tosylate Revenue Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Niraparib Tosylate Sales Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Niraparib Tosylate Revenue Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Niraparib Tosylate Sales Share by Country (2016-2027)
Figure 88. Middle East and Africa Niraparib Tosylate Revenue Share by Country (2016-2027)
Figure 89. Turkey Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 90. Saudi Arabia Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 91. UAE Niraparib Tosylate Revenue (2016-2027) & (US$ Million)
Figure 92. Niraparib Tosylate Value Chain
Figure 93. Niraparib Tosylate Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

以下、関連資料のご紹介

ラフダイヤモンドのグローバル市場インサイト・予測（～2027年）

Global Rough Diamonds Market Insights and Forecast to 2027
QY2112C01058 2021年12月 100Pages
本調査資料はラフダイヤモンドの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ラフダイヤモンドの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（八面体、立方体、三角形、その他）、用途別市場規模（婚約指輪、高級ジュエリー、コレクターピース、その他）、主要地域別市...

金属検出可能型シリコーンシートのグローバル市場インサイト・予測（～2027年）

Global Metal Detectable Silicone Sheets Market Insights and Forecast to 2027
QY2112C00442 2021年12月 127Pages
本調査資料は金属検出可能型シリコーンシートの世界市場の現状について調査・分析し、2027年までの市場を予測しました。金属検出可能型シリコーンシートの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（固体シリコーン、スポンジシリコーン）、用途別市場規模（食品・飲料、医薬品、その他）、主要...

フタロ顔料のグローバル市場インサイト・予測（～2027年）

Global Phthalo Pigment Market Insights and Forecast to 2027
QY2112C00820 2021年12月 126Pages
本調査資料はフタロ顔料の世界市場の現状について調査・分析し、2027年までの市場を予測しました。フタロ顔料の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（フタロブルー、フタログリーン）、用途別市場規模（塗料・コーティング剤、インク、プラスチック、その他）、主要地域別市場規模（北米・...

プラスチック包装袋のグローバル市場インサイト・予測（～2027年）

Global Plastic Packaging Bags Market Insights and Forecast to 2027
QY2112C00838 2021年12月 129Pages
本調査資料はプラスチック包装袋の世界市場の現状について調査・分析し、2027年までの市場を予測しました。プラスチック包装袋の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（PP、PE、その他）、用途別市場規模（食品産業、化学、農業、製薬、パーソナル＆ホームケア、その他）、主要地域別市...

液体リン酸塩のグローバル市場インサイト・予測（～2027年）

Global Liquid Phosphites Market Insights and Forecast to 2027
QY2112C00332 2021年12月 96Pages
本調査資料は液体リン酸塩の世界市場の現状について調査・分析し、2027年までの市場を予測しました。液体リン酸塩の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（DPDP、EHDP、PDDP、TNPP）、用途別市場規模（熱安定剤、酸化防止剤、その他）、主要地域別市場規模（北米・アメリカ...

金属製屋根用窓のグローバル市場インサイト・予測（～2027年）

Global Metal Roof Window Market Insights and Forecast to 2027
QY2112C00454 2021年12月 106Pages
本調査資料は金属製屋根用窓の世界市場の現状について調査・分析し、2027年までの市場を予測しました。金属製屋根用窓の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（手動型窓、電動型窓）、用途別市場規模（住宅、商業）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・...

N-アセチル-L-バリンのグローバル市場インサイト・予測（～2027年）

Global N-Acetyl-L-Valine Market Insights and Forecast to 2027
QY2112C00546 2021年12月 85Pages
本調査資料はN-アセチル-L-バリンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。N-アセチル-L-バリンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（医療、農薬、その他）、主要地域別市場規模（北米・アメリ...

ロジウムスパッタリングターゲットのグローバル市場インサイト・予測（～2027年）

Global Rhodium Sputtering Target Market Insights and Forecast to 2027
QY2112C01043 2021年12月 111Pages
本調査資料はロジウムスパッタリングターゲットの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ロジウムスパッタリングターゲットの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（回転式、非回転式）、用途別市場規模（半導体、化学蒸着、物理蒸着、その他）、主要地域別...

物流用包装フィルムのグローバル市場インサイト・予測（～2027年）

Global Packing Film for Logistics Market Insights and Forecast to 2027
QY2112C00727 2021年12月 110Pages
本調査資料は物流用包装フィルムの世界市場の現状について調査・分析し、2027年までの市場を予測しました。物流用包装フィルムの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ストレッチラッピング、シュリンクラッピング）、用途別市場規模（食品物流、機器物流、電子物流、その他）、主要地域別...

オゾン酸化触媒のグローバル市場インサイト・予測（～2027年）

Global Ozone Oxidation Catalyst Market Insights and Forecast to 2027
QY2112C00721 2021年12月 101Pages
本調査資料はオゾン酸化触媒の世界市場の現状について調査・分析し、2027年までの市場を予測しました。オゾン酸化触媒の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（セラムサイト/粘土、活性炭、活性アルミナ、シリコンアルミニウム複合材料）、用途別市場規模（ケミカルパーク処理、都市下水処...

腫瘍・抗がん剤のグローバル市場インサイト・予測（～2027年） Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors…
選択的エストロゲン受容体分解剤のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Selective Estrogen Receptor Degrader Market The global Selective Estrogen Receptor Degrader market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Selective Estrogen Rece…
太陽光エネルギーセル用高純度スパッタリングターゲット材料のグローバル市場インサイト・予測（～2027年） Sputtering is the process of forming a thin film when the object is attached to the target substrate by the sputtering and scattering, and the sputtering target is the material for high-speed particle bombardment. In this report, we counted the high purity sputtering target material with 4N (purity≥…
半導体用高純度スパッタリングターゲット材料のグローバル市場インサイト・予測（～2027年） Sputtering is the process of forming a thin film when the object is attached to the target substrate by the sputtering and scattering, and the sputtering target is the material for high-speed particle bombardment. In this report, we counted the high purity sputtering target material with 4N (purity≥…
オクチノキサート（OMC）のグローバル市場インサイト・予測（～2027年） Octinoxate (OMC) is one of the most commonly used sunscreens in the world. It has an excellent UV absorption curve of 280-310 nm, high absorption rate, good safety, minimal toxicity and good solubility to oily raw materials, so it is widely used in sunscreen (cream, milk, liquid) and other skin care…